Manufacturing Defects – Pharma.Tips

Troubleshooting Tablet Manufacturing Defects: Capping, Sticking, and Beyond

Tablet defects refer to visual, mechanical, or chemical inconsistencies in finished tablets that render them non-compliant with specifications. These defects are typically observed during in-process checks or final quality inspection.…

Resolving Common Capsule Manufacturing Defects: Shell Leakage, Weight Variation, and Splits

Capsule defects refer to undesirable physical, mechanical, or functional attributes observed during manufacturing or inspection. These can compromise product integrity, dosage accuracy, or patient safety. Key defects include:Click to read…

Troubleshooting Injectable Product Defects: Particulate Matter, Fill Volume Deviations, and Turbidity Issues

Injectable product defects refer to any physical, chemical, or microbial issues that render the parenteral product non-compliant with pharmacopeial or regulatory specifications. These defects are detected during in-process checks, visual…

Identifying and Preventing Ointment and Cream Defects: Phase Separation, Air Entrapment, and Grittiness

Defects in ointments and creams refer to undesirable visual, physical, or functional characteristics in the final product that deviate from intended specifications. These defects not only affect appearance but also…

Understanding and Preventing Suspension and Syrup Defects: Sedimentation, Crystallization, and Color Change

Defects in suspensions and syrups refer to undesirable physical or chemical changes that affect product appearance, stability, safety, or efficacy. Unlike solid dosage forms, liquid formulations are more susceptible to…

Identifying and Preventing Dry Powder Inhaler (DPI) Defects: Dose Uniformity, Device Blockage, and Performance Failures

DPIs rely on the patient’s inspiratory effort to disperse a dry powder formulation into respirable particles. Unlike pressurized metered-dose inhalers (pMDIs), they do not require a propellant. The system typically…

Troubleshooting Transdermal Patch Defects: Adhesion Failure, Matrix Crystallization, and Performance Issues

Transdermal patches can be broadly categorized into matrix systems, reservoir systems, adhesive matrix systems, and multilaminate formats. All formats demand a delicate balance of drug release, adhesion performance, and structural…

Identifying and Preventing Primary Packaging Defects: Seal Integrity, Leakers, and Label Misalignment

Primary packaging directly touches the product. Its integrity is critical for protecting drugs from light, oxygen, moisture, microbial ingress, and physical damage. Examples include:Click to read the full article.

Preventing Secondary and Tertiary Packaging Defects: Carton Mix-Ups, Insert Errors, and Tamper-Evidence Failures

Global agencies like USFDA, EMA, CDSCO, and WHO require strict control of labeling and packaging operations. Labeling and secondary packaging are among the top cited areas in regulatory warning letters.Click…

Identifying and Preventing Stability-Induced Defects in Pharmaceuticals: Color Change, Degradation, and Viscosity Loss

Stability-induced defects refer to physical, chemical, microbiological, or functional changes in a pharmaceutical product during its shelf-life that compromise its quality, safety, or efficacy. These changes typically arise from long-term…

Tablet Defects Like Capping and Sticking? Root Cause Analysis and Fixes

Identifying symptoms of tablet manufacturing defects is the first critical step to maintaining quality control. Common visual and operational signals include:Click to read the full article.

Capsule Defects Like Leakage and Weight Variation? Practical Solutions

Manufacturing defects in capsules manifest through various symptoms, including:Click to read the full article.